Physician profile
Juana M Martin
NPI 1285354571
$1,298.65
in general payments reported to CMS, 2019-2025
12 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,097 · 2024: $68.11 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $246.80 | 2023 | Quviviq |
| Abbott Laboratories | $151.57 | 2023 | Infinity |
| Abiomed | $146.80 | 2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $141.44 | 2023 | Andexxa, Breztri |
| Actelion Pharmaceuticals US, INC. | $125.17 | 2023 | Opsumit, Uptravi |
| Teva Pharmaceuticals USA, INC. | $122.62 | 2023 | Austedo Xr |
| Astellas Pharma US INC | $117.74 | 2023 | Veozah |
| Novo Nordisk INC | $93.51 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Corcept Therapeutics | $67.18 | 2024-2025 | Korlym |
| Exact Sciences Corporation | $45.12 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $22.75 | 2023 | Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $17.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juana Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.